Prelude Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Prelude Therapeutics's estimated annual revenue is currently $25.1M per year.
- Prelude Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Prelude Therapeutics has 162 Employees.
- Prelude Therapeutics grew their employee count by -3% last year.
Prelude Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | President and Chief Medical Officer | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Chief Legal Officer | Reveal Email/Phone |
5 | Executive Assistant to President and CMO | Reveal Email/Phone |
6 | Chief Scientific Officer | Reveal Email/Phone |
7 | Chief People Officer | Reveal Email/Phone |
8 | VP Business Development | Reveal Email/Phone |
9 | SVP & Head Strategic Planning & Operations | Reveal Email/Phone |
10 | SVP and Head Strategic Planning and Operations | Reveal Email/Phone |
Prelude Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Prelude Therapeutics?
N/A
Total Funding
162
Number of Employees
$25.1M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Prelude Therapeutics News
2022-03-22 - Prelude Therapeutics to Participate at the Barclays 2022 ...
WILMINGTON, Del., March 11, 2022 (GLOBE NEWSWIRE) -- Prelude Therapeutics Inc. (Nasdaq: PRLD), a clinical-stage precision oncology company,...
2022-03-22 - Prelude Therapeutics Reports Full Year 2021 Financial Results
Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell...
2022-03-22 - Prelude Therapeutics Provides Clinical Update and ...
Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 162 | 71% | N/A |
#2 | $28.7M | 162 | -14% | $7.4M |
#3 | $7.5M | 162 | 5% | N/A |
#4 | $7.5M | 162 | 7% | N/A |
#5 | $15M | 162 | 7% | N/A |